BiomX (PHGE) Current Leases (2022 - 2025)
BiomX (PHGE) posted Current Leases of $1.4 million for Q4 2025, up 10.8% sequentially from $1.3 million in Q3 2025, and up 27.08% YoY from $1.1 million in Q4 2024.
BiomX (PHGE) Current Leases (2022 - 2025) Analysis & Trends
BiomX has reported Current Leases for 4 years, with the latest figure at $1.4 million in Q4 2025.
- Quarterly Current Leases rose 27.08% year-over-year to $1.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.4 million (up 27.08% YoY) and the FY2025 annual result came in at $1.4 million, up 27.08% from the prior year.
- Current Leases improved to $1.4 million in Q4 2025 per PHGE's latest filing, from $1.3 million in the prior quarter.
- Over five years, Current Leases peaked at $7.8 million in Q1 2024 and troughed at $666000.0 in Q4 2023.
- A 4-year average of $1.8 million and a median of $1.1 million in 2024 frame the typical range for Current Leases.
- The sharpest annual moves came in 2023 and 2024: Current Leases slipped 3.06% in 2023, then soared 69.67% in 2024.
- Over 4 years, Current Leases stood at $687000.0 in 2022, then slipped by 3.06% to $666000.0 in 2023, then surged by 69.67% to $1.1 million in 2024, then increased by 27.08% to $1.4 million in 2025.
- According to Business Quant data, Current Leases over the past three periods registered $1.4 million, $1.3 million, and $1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | BiomX | 361,408.40 | -806,591.60 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.44 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | 1.14 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 15, 2024 | 7.82 Mn |
| Dec 31, 2023 | 666,000.00 |
| Dec 31, 2022 | 687,000.00 |